“…6 Recently, some reports have evaluated the prognostic heterogeneity among patients with pN1 lung cancer, and different prognostic subgroups have been suggested. 5,14,15 Results have indicated that patients who have hilar lymph node involvement have a more favorable prognosis compared with patients who have N2 disease, but no statistical significance has been found. 5,16 In other studies, the survival rate among patients with pulmonary lymph node involvement was significantly better than the survival rate among patients with hilar lymph node involvement, 7,14 and recent reports have suggested the possible inclusion of hilar lymph nodes in the N2 lymph node station.…”